CXCR4 and neoplasm: Previous studies have shown that CXCR4 mediates cancer cell adhesion, migration, chemoresistance, and metastasis, and small molecule or peptide inhibitors of CXCR4 such as AMD3100, TF14016, and LY2510924 decreased tumor growth and metastasis [39–41].